Navigation Links
BMP Sunstone Announces Participation in November Investor Conferences
Date:10/31/2008

PLYMOUTH MEETING, Pa., Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP; "BMP Sunstone" or the "Company") today announced that the Company will present at the following conferences:
1. Oppenheimer Annual Healthcare Conference, held at the Waldorf-Astoria

in New York. Management is currently scheduled to present at 10:40 am

ET on Monday, November 3. A webcast of this presentation will be

available via the Company's website at http://www.bmpsunstone.com .

2. Goldman Sachs China Investment Frontier Conference 2008, held at Grand

Hyatt in Beijing on November 3-4, 2008.

3. Credit Suisse Asia Healthcare Conference, held at the Westin in Beijing

on November 5-6, 2008.

4. Lazard Annual Healthcare Conference, held at the St. Regis in New York.

Management is currently scheduled to present at 4:10 pm ET on Tuesday,

November 18.

5. Roth 'China Comes to Vegas' Conference, held at the Wynn in Las Vegas.

Management is currently scheduled to present at 12:30 pm local time on

Friday, November 21.

Investors interested in attending these conferences should contact their respective institutional sales representative.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 50,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
4. BMP Sunstone Reports Second Quarter 2008 Financial Results
5. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
6. BMP Sunstone Announces Participation in September Investor Conference
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... -- According to a new market research ... (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoiesis, Oncology, Immunology & ... CRO) - Global Forecast to 2021", published by MarketsandMarkets, ... for the forecast period of 2016 to 2021. This ... 2021 from USD 73.3 Million in 2016, growing at ...
(Date:1/24/2017)... - BioAmber Inc. (NYSE: BIOA ) today announced ... Rodman & Renshaw, a unit of H.C. Wainwright ... representative of several underwriters, under which the underwriters have ... minimum of 2,105,264 shares of common stock of the ... 1,052,632 shares of common stock of the Company with ...
(Date:1/23/2017)... 23, 2017   Enteris BioPharma, Inc. , announced ... Sanofi to leverage Enteris, proprietary and patented ... develop an oral formulation of one of Sanofi,s preclinical ... Chief Executive Officer and Executive Chairman of Enteris BioPharma, ... the tremendous value our Peptelligence platform program offers in ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... been appointed Vice President, Preclinical Safety and Senior Director, Safety Pharmacology. Dr. ... in India. , Dr. Thomas’ career as an academic and industry preclinical ...
Breaking Biology Technology:
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
Breaking Biology News(10 mins):